Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Cash from Financing Activities (2020 - 2025)

Biomea Fusion (BMEA) posted Cash from Financing Activities of $23.1 million for Q4 2025, up 1074.39% sequentially from $2.0 million in Q3 2025, and up 5496.13% YoY from $413000.0 in Q4 2024.

Biomea Fusion (BMEA) Cash from Financing Activities (2020 - 2025) Analysis & Trends

Biomea Fusion has reported Cash from Financing Activities for 6 years, with the latest figure at $23.1 million in Q4 2025.

  • Quarterly Cash from Financing Activities rose 5496.13% year-over-year to $23.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $67.9 million (up 3970.98% YoY) and the FY2025 annual result came in at $67.9 million, up 3970.98% from the prior year.
  • Cash from Financing Activities advanced to $23.1 million in Q4 2025 per BMEA's latest filing, from $2.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $162.8 million in Q2 2023 and troughed at -$3000.0 in Q1 2021.
  • A 5-year average of $20.4 million and a median of $413000.0 in 2024 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2021 and 2023: Cash from Financing Activities plunged 106.0% in 2021, then jumped 51106.6% in 2023.
  • Over 5 years, Cash from Financing Activities stood at $246000.0 in 2021, then soared by 99.19% to $490000.0 in 2022, then rose by 26.94% to $622000.0 in 2023, then plunged by 33.6% to $413000.0 in 2024, then jumped by 5496.13% to $23.1 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $23.1 million, $2.0 million, and $39.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 14.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -6.05 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 36.24 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.65 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 27.18 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -273.15 Mn
10 Biomea Fusion 97.69 Mn 97.69 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 23.11 Mn
Dec 31, 2025 23.11 Mn
Sep 30, 2025 1.97 Mn
Sep 30, 2025 1.97 Mn
Jun 30, 2025 39.57 Mn
Jun 30, 2025 39.57 Mn
Mar 31, 2025 3.25 Mn
Mar 31, 2025 3.25 Mn
Dec 31, 2024 413,000.00
Dec 31, 2024 413,000.00
Sep 30, 2024 69,000.00
Sep 30, 2024 69,000.00
Jun 30, 2024 1.07 Mn
Jun 30, 2024 1.07 Mn
Mar 31, 2024 116,000.00
Mar 31, 2024 116,000.00
Dec 31, 2023 622,000.00
Dec 31, 2023 622,000.00
Sep 30, 2023 138,000.00
Sep 30, 2023 138,000.00